Online inquiry

IVTScrip™ mRNA-Human ANKRD13D, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16101MR)

This product GTTS-WK16101MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD13D protein. This product can be used in Multilymphoid progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001347901.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 338692
UniProt ID Q6ZTN6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD13D, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16101MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18508MR IVTScrip™ mRNA-Human ANKRD20A4, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD20A4
GTTS-WK22856MR IVTScrip™ mRNA-Human ARAP1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARAP1
GTTS-WK19101MR IVTScrip™ mRNA-Human ANKRD13D, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD13D
GTTS-WK21742MR IVTScrip™ mRNA-Human ARL4C, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARL4C
GTTS-WK16823MR IVTScrip™ mRNA-Human AHNAK2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AHNAK2
GTTS-WK11042MR IVTScrip™ mRNA-Human ADGRG3, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRG3
GTTS-WK12190MR IVTScrip™ mRNA-Human ADAM15, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAM15
GTTS-WK17067MR IVTScrip™ mRNA-Human ANXA8L1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANXA8L1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →